Daniel Behroozan Md is categorized under Dermatologists in Beverly Hills, CA and active since 2009.
Daniel Behroozan Md was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Dermatologists business, which does work in the B2C market, and is classified as a Dermatologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Daniel Behroozan at the company’s single location by writing to 9730 Wilshire Boulevard # 215, Beverly Hills, California CA 90212 or by phoning (310) 205-0111. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Daniel Behroozan Md |
| Contact Person: | Daniel Behroozan |
| Address: | 9730 Wilshire Boulevard # 215, Beverly Hills, California 90212 |
| Phone Number: | (310) 205-0111 |
| Website Address: | dermsurgery.net |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Dermatologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Daniel Behroozan Md was started in 2009 to provide professional Dermatologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Daniel Behroozan for inquiries that concern Daniel Behroozan Md by calling the company number (310) 205-0111, as your correspondence is most welcome. Additionally, the physical location of the single location of Daniel Behroozan Md can be found at the coordinates 34.066943,-118.407624 as well as the street address 9730 Wilshire Boulevard # 215 in Beverly Hills, California 90212.
For its online presence, you may visit Daniel Behroozan Md’s website at dermsurgery.net and engage with its social media outlets through on Twitter and on Facebook.